Hemodynamic Changes and Retrograde Flow in LVAD Failure
Guruprasad A. Giridharan(University of Louisville), Mark S. Slaughter(University of Louisville), Carlo Bartoli, Allen Cheng(Australian Regenerative Medicine Institute), Erin M. Schumer(University of Louisville), Tohid Pirbodaghi(Board of the Swiss Federal Institutes of Technology), Kevin G. Soucy(Johns Hopkins University), Steven C. Koenig(University of Louisville), Gretel Monreal(University of Louisville), Michael A. Sobieski(University of Louisville), Young Joon Choi(Pacific Northwest National Laboratory)
Cited by 18
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Immobilizing Highly Catalytically Active Pt Nanoparticles inside the Pores of Metal–Organic Framework: A Double Solvents Approach
|Journal of the American Chemical Society|2012|930
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study
|PLoS neglected tropical diseases|2010|759